Skip to content

Federal Contractor Profile

Lovelace Biomedical Research Institute

$137M obligated·169 awards·6 agencies·14 NAICS

Federal Contracts

Showing award actions 51–100 of 209 funded award actions, most recent first.

Contracts with positive obligations
169
Funded award actions shown
209
Obligations shown
$137M
Awarding agencies
6

This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.

Award data as of November 5, 2026. Source: USAspending federal award records.

DateAgencyPIIDNAICSDescriptionAmount
Apr 5, 2023Department of DefenseFA9451 AFRL RDKFA945120P0019541380COVID-19 THE PURPOSE OF VIDER IS TO UNDERSTAND THE EFFECTIVENESS OF RF DIRECTED ENERGY RADIATION IN REDUCING THE VIABILITY OF VIRAL AEROSOLS WITH THE GOAL OF RAPIDLY DEVELOPING AND DEPLOYING REMEDIATION METHODS FOR SPACES CONTAMINATED WITH SARS-COV-2$13K
Mar 31, 2023Department of DefenseFA9451 AFRL RDKFA945120P0019541380COVID-19 THE PURPOSE OF VIDER IS TO UNDERSTAND THE EFFECTIVENESS OF RF DIRECTED ENERGY RADIATION IN REDUCING THE VIABILITY OF VIRAL AEROSOLS WITH THE GOAL OF RAPIDLY DEVELOPING AND DEPLOYING REMEDIATION METHODS FOR SPACES CONTAMINATED WITH SARS-COV-2$10K
Dec 16, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NHLBI75N92019F00074541714THE NHLBI REQUIRES THE GENE THERAPY RESOURCE PROGRAM (GTRP) SUPPORT TRANSLATIONAL GENE THERAPY RESEARCH BY PROVIDING RESOURCES AND SERVICES FROM THREE CORE LABORATORIES: 1.) PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY, 2.) PRECLINICAL VECTOR CORE LABORATORY, 3.) CLINICAL COORDINATING CENTER (CCC), WHICH IS NOT REQUIRED TO HAVE ANY LABORATORY CAPABILITIES.$48K
Sep 28, 2022Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50122D00021541714LOVELACE BIOMEDICAL RESEARCH INSTITUTE - BASE (BIO) - IDIQ FOR BARDA BIOLOGICAL ANIMAL MODEL AND MCM DEVELOPMENT$75K
Sep 28, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00003541715NATURAL HISTORY STUDIES IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS. PERIOD OF PERFORMANCE SEPTEMBER 28, 2020 - DECEMBER 31, 2021$440K
Sep 26, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93022F00001541714GLP REPEAT DOSE TOXICOLOGY STUDY FOR BPL-24910$716K
Sep 23, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00002541715CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN PERIOD OF PERFORMANCE SEPTEMBER 18, 2020 - SEPTEMBER 17, 2022$798K
Sep 23, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95021F00001541715CHARACTERIZATION OF A NON-PARALYZING BONT-BASED BIOPHARMACEUTICAL FOR THE TREATMENT OF NEUROPATHIC PAIN$500K
Sep 22, 2022Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS75F40122F19001541690CTP-2022-111127 - SALTS$2.1M
Sep 20, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95022F00001541715ASSESSMENT OF POTENTIAL TREATMENTS FOR DRUG-INDUCED RESPIRATORY DEPRESSION AND OVERDOSE TOXICITY. POP: SEPTEMBER 26, 2022 - MARCH 25, 2023. TASK ORDER 75N95022F00001 (TO1).$149K
Sep 20, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95022F00002541715ASSESSMENT OF POTENTIAL TREATMENTS FOR DRUG-INDUCED RESPIRATORY DEPRESSION AND OVERDOSE TOXICITY. POP: SEPTEMBER 26, 2022 - MARCH 25, 2023. TASK ORDER 75N95022F00002 (TO2).$163K
Sep 20, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95022F00003541715ASSESSMENT OF POTENTIAL TREATMENTS FOR DRUG-INDUCED RESPIRATORY DEPRESSION AND OVERDOSE TOXICITY. POP: SEPTEMBER 26, 2022 - SEPTEMBER 25, 2023. TASK ORDER 75N95022F00003 (TO3).$103K
Sep 16, 2022Department of DefenseW4PZ USA MED RSCH ACQUIS ACTW81XWH22P0157511210LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR.$212K
Sep 14, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NHLBI75N92022F00250561320NIH/NHBLI/PSB LAB RESEARCHER REQUIRES MOUSE STUDY OF SMOKING REQUIRED IN ORDER TO TO FOLLOW UP ON RESEARCH AIMS OF LEVY LAB AND CONTINUE DEVELOPING THERAPEUTIC TARGET. [22-018080]$25K
Sep 9, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NHLBI75N92022F00001541714GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY$1.3M
Aug 31, 2022Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50122D00013541714LOVELACE BIOMEDICAL RESEARCH INSTITUTE (RADNUC) - IDIQ FOR BARDA CRN ANIMAL MODEL DEVELOPMENT$75K
Aug 31, 2022Department of DefenseDEFENSE HEALTH AGENCYHT001122F0101541714MILITARY MEDICAL RESEARCH AND DEVELOPMENT SERVICES$3K
Aug 3, 2022Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50122F61001541711SUPPORT NON-CLINICAL IMMUNOGENICITY STUDIES OF SARS-COV-2 MICRONEEDLE PATCH VACCINES CANDIDATES IN A SMALL-ANIMAL MODEL$461K
Jul 27, 2022Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50122D00008541714LOVELACE BIOMEDICAL RESEARCH INSTITUTE(CHEM) - IDIQ FOR BARDA CRN ANIMAL MODEL DEVELOPMENT$75K
Jul 22, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95019F00088541715DISEASE MODEL CHARACTERIZATION AND DEVELOPMENT OF ASSAYS TO EVALUATE AND MEASURE PAIN IN A PORCINE MODEL FOR SICKLE CELL DISEASE (SCD)$675K
Jun 23, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95019D00030541715CRO SUPPORT FOR NCATS MEDICINAL CHEMISTRY FOR LEAD OPTIMIZATION.$4K
Jun 16, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95022F00001541715BIOANALYTICAL SUPPORTS FOR A GLP TOX/BIODISTRIBUTION STUDY IN MINI-PIGS$748K
Jun 13, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00005541715EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN PROPIONIC ACIDEMIA (PA) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT. PERIOD OF PERFORMANCE SEPTEMBER 25, 2020 - SEPTEMBER 24, 2022$172K
May 11, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95021F00001541715CHARACTERIZATION OF A NON-PARALYZING BONT-BASED BIOPHARMACEUTICAL FOR THE TREATMENT OF NEUROPATHIC PAIN$71K
Apr 6, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95019F00088541715DISEASE MODEL CHARACTERIZATION AND DEVELOPMENT OF ASSAYS TO EVALUATE AND MEASURE PAIN IN A PORCINE MODEL FOR SICKLE CELL DISEASE (SCD)$227K
Apr 6, 2022Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00002541715CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN PERIOD OF PERFORMANCE SEPTEMBER 18, 2020 - SEPTEMBER 17, 2022$370K
Mar 8, 2022Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA75A50122F61001541711SUPPORT NON-CLINICAL IMMUNOGENICITY STUDIES OF SARS-COV-2 MICRONEEDLE PATCH VACCINES CANDIDATES IN A SMALL-ANIMAL MODEL$295K
Dec 16, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NHLBI75N92019F00074541714THE NHLBI REQUIRES THE GENE THERAPY RESOURCE PROGRAM (GTRP) SUPPORT TRANSLATIONAL GENE THERAPY RESEARCH BY PROVIDING RESOURCES AND SERVICES FROM THREE CORE LABORATORIES: 1.) PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY, 2.) PRECLINICAL VECTOR CORE LABORATORY, 3.) CLINICAL COORDINATING CENTER (CCC), WHICH IS NOT REQUIRED TO HAVE ANY LABORATORY CAPABILITIES.$60K
Dec 3, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00004541715CHARACTERIZATION OF A DOWNSTREAM GENE THERAPEUTIC FOR THE REPARATIVE TREATMENT OF SEVERE FRACTURES PERIOD OF PERFORMANCE SEPTEMBER 24, 2020 - NOVEMBER 23, 2021$180K
Nov 15, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95019F00088541715DISEASE MODEL CHARACTERIZATION AND DEVELOPMENT OF ASSAYS TO EVALUATE AND MEASURE PAIN IN A PORCINE MODEL FOR SICKLE CELL DISEASE (SCD)$255K
Nov 12, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93022F00001541715THE CONTRACTOR SHALL PERFORM THE TRANSFER, VALIDATION AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DETECTION OF CABOTEGRAVIR AND LEVONORGESTREL IN RAT AND NONHUMAN PRIMATE PLASMA$486K
Sep 28, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95021F00002541715EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN METHYL MELANOMIC ACIDEMIA (MMAB) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT.$624K
Sep 24, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00004541715CHARACTERIZATION OF A DOWNSTREAM GENE THERAPEUTIC FOR THE REPARATIVE TREATMENT OF SEVERE FRACTURES PERIOD OF PERFORMANCE SEPTEMBER 24, 2020 - NOVEMBER 23, 2021$282K
Sep 24, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95021F00001541715CHARACTERIZATION OF A NON-PARALYZING BONT-BASED BIOPHARMACEUTICAL FOR THE TREATMENT OF NEUROPATHIC PAIN$584K
Sep 8, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00003541715NATURAL HISTORY STUDIES IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS. PERIOD OF PERFORMANCE SEPTEMBER 28, 2020 - DECEMBER 31, 2021$63K
Sep 7, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95019F00088541715DISEASE MODEL CHARACTERIZATION AND DEVELOPMENT OF ASSAYS TO EVALUATE AND MEASURE PAIN IN A PORCINE MODEL FOR SICKLE CELL DISEASE (SCD)$595K
Sep 3, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NHLBI75N92021F00001541714GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY/TOXICOLOGY CORE LABORATORY - SCIENTIFIC PROJECT FOR RSA NO. 2057 (RADER)$1.6M
Aug 31, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93021F00001541714COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS$2K
Aug 30, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00002541715CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN PERIOD OF PERFORMANCE SEPTEMBER 18, 2020 - SEPTEMBER 17, 2022$269K
Aug 27, 2021Department of DefenseFA8052 773 ESS0011541712IGF::OT::IGF OMNIBUS III / O3-127AF PAIN MANAGEMENT PROGRAM MANAGEMENT SUPPORT$270K
Aug 23, 2021Department of DefenseW4PZ USA MED RSCH ACQUIS ACTW81XWH17C0235511210IGF::OT::IGF ANIMAL MANAGEMENT SYSTEM SOFTWARE LICENSE/SUPPORT$202K
Aug 19, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NHLBI75N92020F00001541714GENE THERAPY RESEARCH PROGRAM (GTRP) - PHARMACOLOGY/TOXICOLOGY CORE LABORATORY: TASK AREA D - RSA NO. 2041$71K
Jul 15, 2021Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCSHHSF22301003T541720IGF::OT::IGF: INVESTIGATE SUBJECTIVE EFFECTS AND NICOTINE PHARMACOKINETICS OF MENTHOLATED SMOKELESS TOBACCO PRODUCTS IN CURRENT USERS$22K
Jun 15, 2021Department of DefenseFA9451 AFRL RDKFA945120P0019541380COVID-19 THE PURPOSE OF VIDER IS TO UNDERSTAND THE EFFECTIVENESS OF RF DIRECTED ENERGY RADIATION IN REDUCING THE VIABILITY OF VIRAL AEROSOLS WITH THE GOAL OF RAPIDLY DEVELOPING AND DEPLOYING REMEDIATION METHODS FOR SPACES CONTAMINATED WITH SARS-COV-2$100K
Jun 1, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93020F00001541711PRE-CLINICAL MODELS OF INFECTIOUS DISEASES TASK ORDER B07$340K
May 25, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00002541715CHARACTERIZATION OF A NON-ADDICTIVE SMALL MOLECULE THERAPEUTICS FOR THE MANAGEMENT OF NON-CANCER PAIN PERIOD OF PERFORMANCE SEPTEMBER 18, 2020 - SEPTEMBER 17, 2022$224K
Apr 6, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID75N93021F00002541715THE PURPOSE OF THIS TASK ORDER IS THE DEVELOPMENT AND DELIVERY OF A QUALITY ASSURANCE/QUALITY CONTROL (QA/QC) PLAN AND PARTICIPATION IN THE TASK ORDER INITIATION MEETING.$19K
Mar 1, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95019F00088541715DISEASE MODEL CHARACTERIZATION AND DEVELOPMENT OF ASSAYS TO EVALUATE AND MEASURE PAIN IN A PORCINE MODEL FOR SICKLE CELL DISEASE (SCD)$415K
Jan 15, 2021Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIDA75N95020F00004541715CHARACTERIZATION OF A DOWNSTREAM GENE THERAPEUTIC FOR THE REPARATIVE TREATMENT OF SEVERE FRACTURES PERIOD OF PERFORMANCE SEPTEMBER 24, 2020 - NOVEMBER 23, 2021$102K
Dec 3, 2020Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NHLBI75N92019F00074541714THE NHLBI REQUIRES THE GENE THERAPY RESOURCE PROGRAM (GTRP) SUPPORT TRANSLATIONAL GENE THERAPY RESEARCH BY PROVIDING RESOURCES AND SERVICES FROM THREE CORE LABORATORIES: 1.) PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY, 2.) PRECLINICAL VECTOR CORE LABORATORY, 3.) CLINICAL COORDINATING CENTER (CCC), WHICH IS NOT REQUIRED TO HAVE ANY LABORATORY CAPABILITIES.$397K

Get Alerted Before Lovelace Biomedical Research Institute's Next Recompete

Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.

Start for free